Skip to main content
Caplight Logo









GenoME Diagnostics Ltd

GenoME Diagnostics Ltd

Private
BelfastHealthcare & Life Scienceshttps://genomediagnostics.co.uk/

Last Round

Grant

Mar 6, 2023

Total Funding Raised

$2.73M

Company Overview

GenoME Diagnostics Ltd is a biotechnology company that develops blood-based diagnostic tests for the early detection and monitoring of cancer using a proprietary DNA methylation and fragmentomic platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

liquid biopsydroplet digital PCRddPCRepigenetic testingcancer diagnosticsearly cancer detectionbiomarker discoveryDNA methylationcompanion diagnosticsfragmentomicsprecision medicinecancer screeningmulti-cancer early detectionMCEDclinical diagnosticsbiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GenoME Diagnostics Ltd Comparables

Compare GenoME Diagnostics Ltd with similar companies based on industry and business-model similarity.

GenoME Diagnostics Ltd comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CpG Diagnostics, Inc.
85%
EarlyDiagnostics
81%
Exai Bio
80%

GenoME Diagnostics Ltd Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 6, 2023
SeedMar 6, 2023
SeedMay 25, 2021

Key People

Founding team and executive leadership

Shannon Beattie

Chief Executive Officer

Executive Team

GenoME Diagnostics Ltd Investors

Notable investors and investment history

GenoME Diagnostics Ltd investors
InvestorRounds
QUBISSeed
Innovate UKGrant
Clarendon Fund ManagersSeed
Deepbridge CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 8, 2025

    Monthly visitors increased 36% MoM.

  • Jun 1, 2025

    Monthly visitors increased 31% MoM.

GenoME Diagnostics Ltd Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

GenoME Diagnostics Ltd Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GenoME Diagnostics Ltd's valuation, stock price, and market status.

Firmographic Details

HeadquartersBelfast
Employee Range5
Year Founded2020
Last FundingMar 6, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?